Back to Search Start Over

Market News.

Source :
Inpharma Weekly; 8/2/2008, Issue 1649, p20-23, 4p
Publication Year :
2008

Abstract

This section offers news briefs on drug approvals as of August 2008. The U.S. Food and Drug Administration (FDA) Arthritis Advisory Committee has recommended the approval of tocilizumab Actemra from Roche for the treatment of rheumatoid arthritis (RA). FDA rejected the approval of Alprostadil from NexMed Inc. for the treatment of erectile dysfunction based on the results of a 2002 carcinogenicity study in mice. The Medical Products Agency of Sweden has approved the ciprofloxacin ProQuin XR from Depomed and Rottapharm.

Details

Language :
English
ISSN :
11738324
Issue :
1649
Database :
Complementary Index
Journal :
Inpharma Weekly
Publication Type :
Periodical
Accession number :
33908943